Annalise Abiodun, MD
Dermatology · Mc Lean
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Kaiser Foundation Health Plan of the Mid Atlantic States, Inc · 1,921 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abiodun’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A161265 · Cancelled
Licence status: Cancelled · since 2019 · University of Utah School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Maryland D0089897Physician · since 2020 · expires 2028-09-30Specialty on the licence: DermatologyTold the state board they are board certified.ActiveNo board action on this licenceCheck it with the state
- Virginia 0101269656Physician · since 2020 · expires 2028-04-30Told the state board they are board certified.Current ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
3 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Surgerycertified 2021
- Dermatologycertified 2019 · through 2029
Education
- University Of Utah School Of Medicine - Salt Lake City UT2015
Residency and fellowship
- California Skin Institute, Mohs Micrographic Surgery and Cosmetic SurgeryMountain View, CA · 2020
- Oregon Health & Science University, DermatologyPortland, OR · 2019
- Greater Baltimore Medical Center, Medical InternshipTowson, MD · 2016
Original Medicare doctor bills
$19,814
Medicare paid this office $19,814 for 23 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 17 | $11,159 | $507 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin cancer | 29 | More than 13% of doctors who do this |
| Removal of skin lesions | 13 | More than 60% of doctors who do this |
Who their Medicare patients are
23 Original Medicare patients in 2024. Average age 75 · Under 65 0% · Also on Medicaid 0% · Health risk score 0.57. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
The office billed $95,622, Medicare allowed $26,152 and paid $19,814; for 54 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 23 | 54 | 75 | 0.57 | $95,622 | $19,814 |
| 2023 | 17 | 47 | 75 | 0.87 | $74,007 | $15,334 |
| 2022 | 16 | 38 | 76 | 0.80 | $55,829 | $12,658 |
| 2021 | 27 | 66 | 74 | 0.67 | $125,710 | $29,280 |
| 2020 | 74 | 333 | 80 | 1.26 | $74,471 | $26,693 |
| 2019 | 86 | 356 | 77 | 0.90 | $54,763 | $22,072 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 17 | $8,372 | $465 |
2021: 2 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 20 | $11,399 | $543 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 12 | $7,571 | $398 |
2020: 7 services
| Destruction of precancer skin growth, 15 or more growths | 12 | $2,242 | $149 |
| Short return visit (20+ min) | 28 | $2,110 | $64 |
| Return visit (30+ min) | 19 | $2,052 | $85 |
| Destruction of skin growth, 1-14 growths | 18 | $1,418 | $79 |
| Destruction of precancer skin growth, 1 growth | 19 | $1,046 | $48 |
| Short return visit | 16 | $759 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 17 | $704 | $6 |
2019: 6 services
| Return visit (30+ min) | 36 | $3,629 | $96 |
| Destruction of skin growth, 1-14 growths | 26 | $2,603 | $93 |
| Short return visit (20+ min) | 28 | $2,119 | $68 |
| Destruction of precancer skin growth, 1 growth | 30 | $1,502 | $43 |
| Short return visit | 17 | $828 | $41 |
| Destruction of precancer skin growth, 2-14 growths | 22 | $698 | $5 |
Drugs they prescribed that Part D paid
$2,486
Pharmacies billed $2,486 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 210) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
210 generic and 0 brand-name prescriptions · $2,486 in drug cost · 85 antibiotic prescriptions to 84 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mupirocin | 106 | $1,476 | $13 |
| Cephalexin | 73 | $578 | $8 |
| Doxycycline Monohydrate | 11 | $107 | $10 |
Year by year
| 2024 | 210 | 189 | 0% (0) | 0% | $2,486 |
| 2023 | 183 | 165 | 0% (0) | None | $1,971 |
| 2022 | 235 | 184 | 0% (0) | 0% | $2,925 |
| 2021 | 305 | 231 | None | None | $4,041 |
| 2020 | 208 | 137 | None | None | $4,540 |
| 2019 | 108 | 74 | None | None | $3,044 |
| 2018 | 85 | 42 | None | 15% | $6,045 |
| 2017 | 361 | 189 | None | 16% | $155,757 |
| 2016 | 111 | 55 | None | 23% | $90,187 |
| 2015 | 14 | None | None | None | $926 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Mupirocin | 86 | $1,013 | $12 |
| Cephalexin | 75 | $597 | $8 |
| Doxycycline Monohydrate | 12 | $117 | $10 |
2022: 3 drugs
| Mupirocin | 82 | $1,057 | $13 |
| Cephalexin | 103 | $833 | $8 |
| Doxycycline Monohydrate | 26 | $256 | $10 |
2021: 4 drugs
| Cephalexin | 179 | $1,433 | $8 |
| Mupirocin | 29 | $374 | $13 |
| Doxycycline Monohydrate | 36 | $348 | $10 |
| Triamcinolone Acetonide | 12 | $99 | $8 |
2020: 4 drugs
| Cephalexin | 79 | $545 | $7 |
| Triamcinolone Acetonide | 25 | $281 | $11 |
| Doxycycline Monohydrate | 25 | $233 | $9 |
| Mupirocin | 15 | $186 | $12 |
2019: 3 drugs
| Triamcinolone Acetonide | 24 | $285 | $12 |
| Doxycycline Monohydrate | 14 | $172 | $12 |
| Cephalexin | 18 | $95 | $5 |
2018: 1 drug
| Clobetasol Propionate | 16 | $2,647 | $165 |
2017: 10 drugs
| Clobetasol Propionate | 35 | $5,077 | $145 |
| Fluorouracil | 20 | $4,107 | $205 |
| Tacrolimus | 12 | $2,516 | $210 |
| Betamethasone Dipropionate | 21 | $1,649 | $79 |
| Hydroxychloroquine Sulfate | 11 | $1,337 | $122 |
| Methotrexate | 16 | $984 | $62 |
| Triamcinolone Acetonide | 32 | $559 | $17 |
| Doxycycline Monohydrate | 11 | $300 | $27 |
| Mupirocin | 12 | $130 | $11 |
| Hydrocortisone | 14 | $99 | $7 |
2016: 1 drug
| Methotrexate | 16 | $1,025 | $64 |
Money from drug and device companies
$126 in 2020
| 2020 | 4 | 7 | None | $126 |
| 2019 | 5 | 7 | None | $471 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Erivedge | $41 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $35 | 2 payments
|
| AbbVie | Skyrizi | $33 | 2 payments
|
| Dermira | Qbrexza | $17 | 1 payment
|
See all 7 published payments
| AbbVie | Meals · 2020-10-20 | Skyrizi | $15 |
| AbbVie | Meals · 2020-05-05 | Skyrizi | $18 |
| Genentech USA | Meals · 2020-03-13 | Erivedge | $18 |
| Dermira | Meals · 2020-03-04 | Qbrexza | $17 |
| Novartis Pharmaceuticals | Meals · 2020-02-11 | Cosentyx | $17 |
| Novartis Pharmaceuticals | Meals · 2020-01-22 | Cosentyx | $18 |
| Genentech USA | Meals · 2020-01-10 | Erivedge | $23 |
See earlier years (2019)
2019: $471
| AbbVie | Humira | $167 | 3 payments
|
| Solta Medical a division of Bausch Health US | None | $109 | 1 payment
|
| Allergan | None | $97 | 1 payment
|
| Almirall | None | $78 | 1 payment
|
| Lilly USA | Taltz | $21 | 1 payment
|
Professional record
- NPI
- 1437545498
- Licence
- CA A161265, DC MD048435, MD D0089897, VA 0101269656California A161265: CancelledMaryland D0089897: ActiveVirginia 0101269656: Current Active
- Trained
- University of Utah School of Medicine, 2015
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ND0101X (207ND0101X); Federal specialty code 207NS0135X (207NS0135X)
- Mailing address
- 8008 Westpark Dr, Mc Lean, VA, 22102
- NPI first listed
- 2015-04-07
- NPI last updated
- 2021-06-04
- NPI record certified
- 2021-06-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 525 South Dr Ste 115, Mountain View, CA, 94040 · 6565 N Charles St, Towson, MD, 21204
This office lists an electronic records connection.